Free knowledge to monitor the world of events. Have a look at our must read Blogs on Pharma, Finance, HR, Health and Cross Industry.
Cannabis & Pharma
2022-08-16
Our previous blog we spoke of Advanced E-Pil. So, let’s explore on something that many of us didn’t know, the science behind cannabis in the pharma industry.
Cannabis, has been used for medicinal and recreational purposes for thousands of years. Recently, there has been a renewed interest in its potential benefits in the biotechnology, pharmaceutical, and nutraceutical industries. In this blog post, we will explore some of the ways in which cannabis is being used in these industries and the benefits it provides.
Cannabis in Biotechnology
Biotechnology is a rapidly growing field that involves the use of living organisms, such as plants and bacteria, to develop new products and technologies. Cannabis is a particularly useful plant for biotechnology research because it contains a wide variety of active compounds, including cannabinoids, terpenes, and flavonoids, which have been shown to have a range of therapeutic effects. One area of biotechnology research that has benefited greatly from cannabis is genetic engineering. Scientists have been able to manipulate the genetic makeup of cannabis plants to produce strains that are high in specific cannabinoids, such as THC or CBD. This has allowed researchers to better understand the effects of these compounds on the human body and develop new treatments for a variety of medical conditions.
Cannabis in Pharmaceuticals
The pharmaceutical industry is one of the largest and most important industries in the world, responsible for developing and producing medicines that help to treat and cure a wide range of diseases and illnesses. Cannabis is becoming an increasingly important part of this industry, as researchers continue to discover new ways in which it can be used to treat medical conditions. One of the most well-known uses of cannabis in the pharmaceutical industry is for pain relief. THC, the main psychoactive compound in cannabis, has been shown to be an effective pain reliever, particularly for chronic pain conditions such as multiple sclerosis and neuropathic pain. In addition, CBD, another compound found in cannabis, has been shown to have anti-inflammatory properties and may be useful in treating conditions such as rheumatoid arthritis.
Another area where cannabis is being used in the pharmaceutical industry is in the treatment of neurological disorders. Studies have shown that cannabis may be effective in treating conditions such as epilepsy, Parkinson's disease, and Alzheimer's disease, as well as providing relief for symptoms such as tremors and seizures.
What are Nutraceuticals
Nutraceuticals are food products that have been fortified with bioactive compounds that have a positive effect on human health. Cannabis is increasingly being used in the nutraceutical industry because it contains a wide variety of bioactive compounds, including cannabinoids, terpenes, and flavonoids. One of the most promising areas of research in the nutraceutical industry is the use of cannabis for the treatment of anxiety and depression. Studies have shown that CBD, a non-psychoactive compound found in cannabis, may be effective in treating these conditions, as well as providing relief for symptoms such as insomnia and stress.
Cannabis is also being used in the nutraceutical industry for its anti-inflammatory properties. Studies have shown that both THC and CBD have anti-inflammatory effects, which may be useful in treating conditions such as arthritis and inflammatory bowel disease.
Conclusion
In conclusion, cannabis is becoming an increasingly important part of the biotechnology, pharmaceutical, and nutraceutical industries. Its wide variety of active compounds and therapeutic effects make it a valuable resource for researchers and companies looking to develop new products and treatments. As research continues, it is likely that we will see even more innovative uses of cannabis in these industries, providing new and exciting opportunities for growth and development.
Do you want to understand more about Cannabis in Pharmaceutical? Join our upcoming Cannabis for the Biotechnology, Pharmaceutical and Nutraceutical Industry - US edition MasterClass!
By Nafhan Naseem, Jr. Social Media Executive & IT Support, GLC Europe, Colombo Office, Sri Lanka.
Get a feel for our events
Entry Level Process Validation for Biotechnological Products MasterClass - EU edition
18-21 November, 2024
QbD concept, process validation, and regulatory requirements!
learn more >>CRO Oversight MasterClass - EU edition
18-21 November, 2024
How to design and implement the systems your company needs.
learn more >>CRO Oversight MasterClass - US edition
18-21 November, 2024
The latest revision to ICH GCP
learn more >>